Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection (Q46743934)

24 December 2017

title

Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection (English)

1 reference

24 December 2017

author

John R. Falck

5

1 reference

24 December 2017

author name string

Kasem Nithipatikom

1

1 reference

24 December 2017

Michael P Endsley

2

1 reference

24 December 2017

Jeannine M Moore

3

1 reference

24 December 2017

Marilyn A Isbell

4

1 reference

24 December 2017

William B Campbell

6

1 reference

24 December 2017

Garrett J Gross

7

1 reference

24 December 2017

publication date

7 October 2005

1 reference

24 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

24 December 2017

volume

290

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

H500-5

1 reference

24 December 2017

Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Beating ischemia: a new feat of EETs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Cytochrome P450: major player in reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Delta-opioid receptor activation mimics ischemic preconditioning in the canine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

Effects of a 20-HETE antagonist and agonists on cerebral vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00918.2005

10.1152/AJPHEART.00918.2005

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16214838

1 reference

24 December 2017